Pharmaceutical Technology21 分钟
Risk adjusted net present value: What is the current valuation of Sanofi’s Duvakitug?
Duvakitug is a monoclonal antibody commercialized by Sanofi, with a leading Phase II program in Ulcerative Colitis;Crohn's Disease (Regional Enteritis).
Pharmaceutical Technology36 分钟
Risk adjusted net present value: What is the current valuation of Armata Pharmaceuticals ...
APSA-02 is a biologic commercialized by Armata Pharmaceuticals, with a leading Phase II program in Bacteremia.
studyfinds3 小时
Hidden dangers under your feet: How soil bacteria could lead to deadly infections
Researchers have found that the soil we walk on is far more than just dirt; it may be harboring tiny genetic codes that ...